TFAM and posterior cortical atrophy: Further survival analysis based on TFAM mRNA expression level (cut off at 4.71) demonstrates that PCa patients who have lower TFAM expression are likely to be disease free, when compared to PCa patients who have high TFAM expression, at >0.3 year time frame.